Future trends in hematopoietic stem cell transplantation.

Area of Science:

• Hematology
• Immunology
• Transplantation Medicine

Background:

• Hematopoietic stem cell transplantation (HSCT) is a growing treatment modality for hematological disorders.
• Indications for HSCT are expanding to include non-hematological conditions like genetic, metabolic, and autoimmune diseases.
• Increased HSCT survival necessitates addressing long-term organ-specific effects and chronic graft-versus-host disease (cGVHD).

Purpose of the Study:

• To review key issues and emerging trends in hematopoietic stem cell transplantation.
• To highlight the expanding scope of HSCT indications and its implications for patient management.
• To emphasize the challenges posed by chronic graft-versus-host disease (cGVHD) and other post-transplant complications.

Main Methods:

• Review of current literature and recent publications on HSCT.
• Analysis of trends in HSCT indications, graft manipulation, and donor selection.
• Discussion of advancements in managing graft-versus-host disease (GVHD) and immune reconstitution.

Main Results:

• HSCT is increasingly used for both malignant and non-malignant hematological disorders, with potential expansion to other severe diseases.
• Long-term survivors face significant risks of organ-specific late effects and chronic graft-versus-host disease (cGVHD).
• Graft manipulation and donor selection influence immune reconstitution and post-transplant complications, including infectious and immunological disorders.

Conclusions:

• Hematopoietic stem cell transplantation (HSCT) is a rapidly evolving field with expanding applications and improved survival rates.
• Managing chronic graft-versus-host disease (cGVHD), recognized as a complex systemic disease, remains a critical priority.
• Future efforts in HSCT will focus on refining techniques to minimize GVHD while enhancing graft-versus-tumor effects and improving long-term patient outcomes.